Search for: "Mylan, Inc." Results 301 - 320 of 587
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against Wockhardt… [read post]
18 Jul 2012, 4:52 am
Given a narrow interpretation, the Mylan product would not infringe. [read post]
9 Apr 2010, 8:30 am by Lucas A. Ferrara, Esq.
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
25 Oct 2009, 3:46 am
Ivax read the Lanham Act broadly; by contrast, Mylan Labs., Inc. v. [read post]
6 Jun 2007, 9:39 am
The fact that Mylan Laboratories is already marketing a generic competition to Norvasc, Pfizer's reply said, does not mean that Pfizer would not be able to get "further equitable relief" against Mylan and other generics during the remaining period of exclusivity for Pfizer. [read post]
26 Feb 2014, 5:37 pm
  Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
18 Apr 2012, 1:29 pm by Bexis
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
31 Jul 2013, 2:30 pm by Lawrence B. Ebert
Mylan Labs., Inc., 464 F.3d 1286, 1290 (Fed. [read post]
14 Nov 2012, 1:51 pm
Mylan Labs., Inc., 520 F.3d 1358, 1364-65 (Fed. [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
25 May 2007, 11:36 am
Mylan Laboratories, Inc., et al., and  Ormco Corporation, et al. v. [read post]
10 Jul 2012, 5:49 pm by FDABlog HPM
  In the litigation, our firm represented Metrics, Inc., doing business as Coastal Pharmaceuticals, and Mylan Pharmaceuticals Inc., which markets the generic product. [read post]